Squarepoint Ops LLC Athira Pharma, Inc. Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.36 - $3.59 $13,761 - $20,933	-5,831 Reduced 34.54%	11,051 $32,000
Q1 2023 May 15, 2023	SELL	$2.26 - $4.22 $734 - $1,371	-325 Reduced 1.89%	16,882 $42,000
Q4 2022 Feb 14, 2023	BUY	$2.76 - $3.71 $47,491 - $63,837	17,207 New	17,207 $54,000
Q2 2022 Aug 15, 2022	BUY	$2.74 - $13.43 $87,603 - $429,383	31,972 New	31,972 $98,000
Q1 2021 May 17, 2021	SELL	$16.9 - $29.77 $338,000 - $595,400	-20,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$16.48 - $34.3 $300,446 - $625,323	-18,231 Reduced 47.69%	20,000 $685,000
Q3 2020 Nov 16, 2020	BUY	$16.02 - $18.46 $612,460 - $705,744	38,231 New	38,231 $706,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.2M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.